Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Molecular Data Inc. (MKDTY)
Shanghai, CN
Molecular Data Inc. (MDI), operating through its various subsidiaries, specializes in digital commerce for the chemical sector within China. The company leverages an advanced technology platform to seamlessly connect stakeholders across the entire chemical supply chain by offering a comprehensive suite of integrated solutions. These offerings include digital commerce services, financial solutions, warehousing and logistics management, and bespoke Software-as-a-Service (SaaS) applications, all tailored for participants in the traditional chemical industry. MDI's e-commerce presence is primarily facilitated through its online portals, such as the molbase.com and molbase.cn websites, the Moku Data Weixin account, the Chemical Community mobile application, and other supporting digital channels. Established in 2013, Molecular Data Inc. maintains its primary operational base in Shanghai, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | +0.00% | +0.00% | +9,900.00% | +0.00% | -66.67% | -99.81% | -99.97% | -99.97% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
| Rating | 2024-06 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals: +4.0%-42.7%
-
EPS growth Chemicals: +11.7%-52.7%
-
FCF margin FCF growth · Chemicals: +41.7%-3.8% Q4'19: -0.1%
-
EBIT margin Chemicals: +7.1%-4.1% Q4'19: -1.4%
-
ROIC Chemicals: +3.4%— Q4'19: +87.9%
-
Share dilution Chemicals: +0.0%+12.1%
-
Debt / EBITDA Net debt/EBITDA · Chemicals: 0.55×-0.23× Q4'19: -0.33×
| Metric |
Dec 2020 actual |
Dec 2021 actual |
|---|---|---|
| Revenue |
7.60B
est: 7.60B (+0.0%)
|
10.15B
est.
|
| EBITDA |
-313.13M
est: -204.94M (-52.8%)
|
-273.96M
est.
|
| EBIT |
-314.85M
est: -207.04M (-52.1%)
|
-276.77M
est.
|
| Net Income |
-328.04M
|
—
est.
|
| SGA |
277.42M
est: 212.88M (+30.3%)
|
284.58M
est.
|
| EPS |
-42.40
|
—
est.
|
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Dongliang Chang | Founder & Chairman of Board of Directors | — | — |
| Jingming Zhong | Compliance Officer | — | male |
| Steven Foo | Chief Executive Officer & Chief Financial Officer | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for MKDTY
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
